E Tomas Selected Research

C-Reactive Protein

8/2011

The effect of hysterectomy or levonorgestrel-releasing intrauterine system on cardiovascular disease risk factors in menorrhagia patients: a 10-year follow-up of a randomised trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E Tomas Research Topics

Disease

2	Stress Urinary Incontinence 01/2022 - 01/2015
2	Urinary Incontinence 01/2022 - 04/2010
2	Menorrhagia 08/2011 - 04/2010
1	Pelvic Organ Prolapse 01/2022
1	Hypertension (High Blood Pressure) 08/2011
1	Myocardial Ischemia (Ischemic Heart Diseases) 08/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2011
1	Hypercholesterolemia 08/2011
1	Body Weight (Weight, Body) 01/2011
1	Insulin Resistance 01/2011
1	Obesity 01/2011
1	Weight Gain 01/2011
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2011
1	Urinary Tract Infections (Urinary Tract Infection) 04/2010
1	Lower Urinary Tract Symptoms 04/2010

Drug/Important Bio-Agent (IBA)

2	Levonorgestrel (Plan B)FDA LinkGeneric 08/2011 - 04/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2011
1	C-Reactive ProteinIBA 08/2011
1	LipidsIBA 08/2011
1	Glucagon (Glukagon)FDA Link 01/2011
1	Glucose (Dextrose)FDA LinkGeneric 01/2011
1	Insulin (Novolin)FDA Link 01/2011
1	Peptides (Polypeptides)IBA 01/2011
1	Triglycerides (Triacylglycerol)IBA 01/2011

Therapy/Procedure

3	Hysterectomy 01/2022 - 04/2010
1	Vaginal Hysterectomy 01/2022
1	Suburethral Slings (Tension-Free Vaginal Tape) 01/2015